Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-07-18
2006-07-18
Campell, Bruce R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S300000, C530S327000, C514S014800, C514S008100, C514S009100
Reexamination Certificate
active
07078380
ABSTRACT:
The invention concerns agents with anti-bacterial activity and methods and intermediates for their production. The present invention further concerns the use of such agents for the treatment of bacterial infections in animals, including man. The agents are derivatives of vancomycin-type antibiotics, of structure: V-L-W-X; wherein V is a glycopeptide moiety which inhibits peptidoglycan biosynthesis in bacteria; L is a linking group; W is a peptidic membrane-associating element such as an element based on naturally-occurring animal or bacterial peptide antibiotics; and X is hydrogen or a membrane-insertive element.
REFERENCES:
patent: 3067099 (1962-12-01), McCormick et al.
patent: 4698327 (1987-10-01), Nagarajan et al.
patent: WO 96/30401 (1996-10-01), None
patent: WO 96/38163 (1996-12-01), None
patent: WO 98/00153 (1998-01-01), None
patent: WO 98/02454 (1998-01-01), None
patent: WO 98/52614 (1998-11-01), None
patent: WO 00/64487 (2000-11-01), None
patent: WO 01/76636 (2001-10-01), None
A Malabarba, et al. Medicinal Research Reviews (1997) 17(1), 69-137.
BCS Chia, et al. Eur. J. Biochem. (2000) 267, 1894-1908.
L Zhang, et al. Biochemistry (2000) 39, 14504-14514.
K Matsuzaki. Biochimica et Biophysica Acta (1999) 1462, 1-10.
K Matsuzaki, et al. Biochemistry (1997) 36, 9799-9806.
F Van Bambeke. Current Opinion in Pharmacology (2004) 4, 471-478.
A King, et al. Journal of Antimicrobial Chemotherapy (2004) 53, 797-803.
Gibson et al., “Bobinin-like Peptides with Antimicrobial Activity from Skin Secretions of the Asian Toad,Bobina orientalis”, The Journal of Biological Chemistry, vol. 266, No. 34, pp 23103-23111 (1991).
Habermann, “Bee and Wasp Venoms”, Science, vol. 177, pp. 314-322 (1972).
Latorre et al., “Voltage-Dependent Channels in Planar Lipid Bilayer Membranes”, Physiological Reviews, vol. 61, No. 1, pp 77-150 (1981).
Sheldrick et al., “Structure of vancomycin and its complex with acetyl-D-alanyl-D-alanine”, Nature, vol. 271, pp 223-225, (1978).
Arthur et al., “Characterization of Tn1546, a Tn3-Related Transposon Conferring Glycopeptide Resistance by Synthesis of Depsipeptide Peptidoglycan Precursors inEnnterococcus faeciumBM4147”, Journal of Bacteriology, vol. 175, No. 1, pp 117-127 (1993).
Dutka-Malen et al., “The VANA glycopeptide resistance protein is related to D-alanyl-D alanine ligase cell wall biosynthesis enzymes”, Mol. Gen. Genet 224, pp 364-372 (1990).
Bugg et al., “Molecular Basis for Vancomycin Resistance inEnterococcus faeciumBM4147: Biosynthesis of a Depsipeptide Peptidoglycan Precursor by Vancomycin Resistance Proteins VanH and VanA”, Biochemistry, vol. 30, No. 43, pp 10408-10415 (1991).
Evers et al., “Regulation of VanB-Type Vancomycin Resistance Gene Expression by the VanSB-VanRBTwo-Component Regulatory System inEnterococcus faecalisV583”, Journal of Bacteriology, vol. 178, No. 5, pp 1302-1309 (1996).
Baptista et al., “Specificity of Induction of Glycopeptide Resistance Genes inEnterococcus faecalis”, Antimicrobial Agents and Chemothereapy, vol. 40, No. 10, pp 2291-2295 (1996).
Billot-Klein et al., “Association constants for the binding of vancomycin and telcoplanin to N-acetyl-D-alanyl-D-alanine and N-acetyl-D-alanyl-D-serine”, Biochemical Journal Letters, vol. 304, pp 1021-1022 (1994).
Reynolds et al., “Analysis of peptidoglycan precursors in vancomycin-resistantEnterococcus gallinarumBM4174”, Biochem Journal, vol. 301, pp 5-8 (1994).
Handwerger et al., “Concomitant High-Level Vancomycin and Penicillin Resistance in Clinical Isolates ofEnterococci”, Clinical Infectious Diseases, vol. 14, pp 665-661 (1992).
Handwerger et al., “Nosocomial Outbreak Due toEnterococcus faeciumHighly Resistant to Vancomycin, Penicillin, and Gentamicin”, Clinical Infectious Diseases, vol. 16, pp 750-5 (1993).
Murray, “The Life and Times of theEnterococcus”, Clinical Microbiology Reviews, vol. 3, No. 1, pp46-65 (1990).
Woodford et al., “Plasmid-Mediated vanB Glycopeptide Resistance inEnterococci”, Microbial Drug Resistance, vol. 1, No. 3, pp 235-240 (1995).
Sundram et al., “General and Efficient Method for the Solution and Solid-Phase Synthesis of Vancomycin Carboxamide Derivatives”, J. Org. Chem., vol. 60, pp 1102-1103 (1995).
Cooper et al., “Reductive Alkylation of Glycopeptide Antibiotics: Synthesis and Antibacterial Activity”, The Journal of Antibiotics, vol. 49, No. 6, pp 575-581 (1996).
Rodriguez et al., “Novel Glycopeptide Antibiotics: N-Alkylated Derivatives Active Against Vancomycin-ResistantEnterococci”, The Journal of Antibiotics, pp 560-569 (1998).
Dong et al., “Strategies for targeting complement inhibitors in ischaemia/reperfusion injury”, Molecular Immunology, vol. 36, pp 957-963 (1999).
Ge et al., “Vancomycin Derivatives That Inhibit Peptidoglycan Biosynthesis Without Binding D-Ala-D-Ala”, Science, vol. 284, pp 507-511 (1999).
Jack et al., “Natural Peptides with Antimicrobial Activity”, Chimia, vol. 52, pp48-55 (1998).
McCafferty et al., “Synergy and duality in peptide antibiotic mechanisms”, Chemical Biology, vol. 3, pp 672-680 (1999).
Dankert et al., “Biomedical Polymers: Bacterial Adhesion, Colonization, and Infection”, CRC Critical Reviews in Biocompatibility, vol. 2, pp 219-301.
Kamal et al., “Reduced Intravascular Catheter Infection by Antibiotic Bonding”, Jama, vol. 265, No. 18, pp 2364-2368 (1991).
Farber et al., “The Use of Nonsteroidal Antiinflammatory Drugs to Prevent Adherence ofStaphylococcus epidermidisto Medical Polymers”, The Journal of Infectious Diseases, vol. 166, pp 861-865 (1992).
Atherton et al., “Solid Phase Peptide Synthesis” IRL Press, Oxford, pp 31-32 & 47-61 (1989).
Betley Jason Richard
Cooper Matthew Allister
Adprotech Limited
Cambridge University Technical Services Limited
Campell Bruce R.
Harness & Dickey & Pierce P.L.C.
Kosar Andrew D.
LandOfFree
Antibacterial agents comprising conjugates of glycopeptides... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibacterial agents comprising conjugates of glycopeptides..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibacterial agents comprising conjugates of glycopeptides... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3556078